Ridley Corporation Limited

RIC

Ridley Corp. Ltd. engages in the production and market of stock feed and animal feed supplements. The company is headquartered in Melbourne, Victoria. The firm operates through two segments: Packaged Feeds and Ingredients and Bulk Stockfeeds. The Packaged Feeds and Ingredients segment comprises animal nutrition feed and ingredient solutions delivered in packaged form, ranging from one ton down to three kilogram bags. The company also includes the Aquafeed Business Unit. The Bulk Stockfeeds segment includes animal nutrition stockfeed solutions delivered in bulk. Its specialist areas include Aqua Feeds, Bulk Ruminant Stockfeeds, Bulk Monogastric Stockfeeds, Animal Proteins & Oils, Commodities, NovaqPro, and Primo Aquaculture. The company manufactures and supplies a complete range of prawn/shrimp feeds and fish feeds for species, including Monodon, Vannamei, Banana, and Stylirostris prawns. The company is also a provider of dairy feed, cattle feed, and sheep feed. The company provides bulk stockfeed for monogastric animals, including layers, broilers, pigs, and ducks.

Riedel Resources Limited

RIE

Riedel Resources Ltd. operates as a mineral exploration company. The company is headquartered in Perth, Western Australia. The company went IPO on 2011-01-31. The firm is focused on advancing the high-grade Kingman Gold Project in North-West Arizona. The firm's geographical segments include Australia, the United States and Spain. The Kingman Gold Project in Arizona comprises approximately 2,191 hectares of contiguous landholding over 110 kilometers (km) southeast of Las Vegas, Nevada. Its Marymia East Gold & Base Project is a joint venture with Norwest Minerals Limited and the Company’s wholly owned subsidiary, Audax Minerals Pty Ltd. The project is located over 200 km north of Meekatharra in Western Australia and comprises two granted exploration tenements (E52/2394 and E52/2395) covering a total area of approximately 240 square kilometers.

Resonance Health Limited

RHT

Resonance Health Ltd. operates as a healthcare company, which involves in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment. The company is headquartered in Perth, Western Australia. Its portfolio includes Core Lab and artificial intelligence (AI)-powered products to partner with clinicians and radiologists for diagnosis, and management of patients. Its core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. Its other SaMDs include Cardiac T2, for the assessment of iron in the heart, and HepaFat-Scan for the assessment of fat in and around the liver. The company also has several AI-assisted SaMDs, including FerriSmart, HepaFat-AI, and LiverSmart. The company operates as the Clinical Trial Research Organisation (CRO) and local sponsor for a major global pharma company's clinical trial in Australia of a new drug compound.

Rhythm Biosciences Limited

RHY

Rhythm Biosciences Ltd. engages in the research, development, and commercialization of medical diagnostics technologies. The firm is engaged in delivering simple, affordable blood tests for accurate and early detection of cancers. The company is focused on improving patient outcomes through detection at the earliest possible stage, reducing the global burden of cancer and saving lives. The firm has developed ColoSTAT, a blood test for the detection of Colorectal Cancer (CRC). If diagnosed early, colorectal cancer is curable. The ColoSTAT Test-Kit measures five specific protein biomarkers that indicate the likelihood of CRC. The test is an alternative for individuals who are unable or unwilling to participate in current screening programs. The company is being updated to meet the IVDR (In vitro diagnostic medical devices regulation) regulatory standards. The company is focused on working with likeminded global partners to achieve commercialization and distribution of these simple solutions.